The role of a multidisciplinary team in a pediatric pulmonary hypertension center

Elise Whalen1, Erin Ely2, Anna Brown3

  • 1Department of Pediatric Pulmonology, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas.

Pediatric Pulmonology
|April 7, 2020
PubMed

Insights

Multidisciplinary teams in pediatric pulmonary hypertension (PH) centers enhance care by addressing complex challenges. These teams provide essential support, resources, and improve quality of life for PH patients.

Area of Science:

  • Pediatric Medicine
  • Cardiology
  • Pulmonology

Background:

  • Pediatric pulmonary hypertension (PH) is a rare and complex condition requiring specialized care.
  • Limited accredited pediatric PH centers and healthcare facility experience pose challenges for patient management.
  • Patients face high medication costs, fragmented care across specialties, and lack of community understanding.

Purpose of the Study:

  • To highlight the critical role of multidisciplinary teams in improving care delivery for pediatric PH patients.
  • To emphasize how structured teams can effectively manage the multifaceted challenges associated with PH.
  • To advocate for the establishment and optimal composition of these specialized care teams.

Main Methods:

  • The study emphasizes a collaborative approach involving various healthcare professionals.
  • Key team members include physicians, advanced practice providers, nurses, dietitians, physiologists, respiratory therapists, social workers, and research coordinators.
  • Subspecialty collaborations with cardiology, pulmonology, genetics, psychology, and palliative care are integral.

Main Results:

  • Multidisciplinary teams can effectively address the challenges of pediatric PH.
  • Clear delineation of tasks and roles ensures comprehensive patient support and resources.
  • Improved patient outcomes and quality of life are achievable through coordinated care.

Conclusions:

  • Multidisciplinary teams are essential for optimizing care in pediatric pulmonary hypertension centers.
  • Team composition should consider patient population heterogeneity, available resources, and community awareness.
  • Referral to expert PH centers is crucial when local expertise is limited, ensuring the best possible outcomes.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
498
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
505
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
377
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
200
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
645
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.0K